Telaprevir in Genotype 3 HCV
Clinical trial NCT02087111 · COMPLETED
Trial details
- NCT number
- NCT02087111
- Sponsor
- Queen Mary University of London
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2016-11-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.